Cytologic diagnosis of metastatic melanoma by FNA: A practical review.
BRAF
fine-needle aspiration
immunocytochemistry
melanoma
sentinel node
Journal
Cancer cytopathology
ISSN: 1934-6638
Titre abrégé: Cancer Cytopathol
Pays: United States
ID NLM: 101499453
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
06
05
2021
accepted:
02
06
2021
pubmed:
27
7
2021
medline:
19
4
2022
entrez:
26
7
2021
Statut:
ppublish
Résumé
Malignant melanoma (MM) is a highly aggressive neoplasm with a growing worldwide incidence. It is not uncommon that the disease is already metastatic at the time of the first diagnosis. Regional lymph nodes and skin are the first and most common metastatic sites, followed by distant visceral sites (lungs, liver, and central nervous system) and bone. In this clinical setting, fine-needle aspiration (FNA) often represents the first diagnostic approach. FNA is a useful tool to obtain a rapid and accurate diagnosis, in conjunction with ancillary techniques and molecular analysis, as recommended by recent guidelines. The aim of this review was to describe the cytomorphology, immunocytochemical tools, and molecular tools used for the diagnosis of MM metastases on FNA.
Identifiants
pubmed: 34310059
doi: 10.1002/cncy.22488
pmc: PMC9292535
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
18-29Informations de copyright
© 2021 The Authors. Cancer Cytopathology published by Wiley Periodicals LLC on behalf of American Cancer Society.
Références
Melanoma Res. 2011 Jun;21(3):228-34
pubmed: 21502902
Cancer Cytopathol. 2020 Apr;128(4):260-268
pubmed: 31985897
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Melanoma Res. 2018 Aug;28(4):319-325
pubmed: 29595571
Cancer Cytopathol. 2020 Dec;128(12):910
pubmed: 32463569
Cancer. 2000 Jun 25;90(3):186-93
pubmed: 10896332
Eur J Cancer. 2019 Jun;114:1-7
pubmed: 31005015
J Natl Cancer Inst. 1986 Nov;77(5):1013-21
pubmed: 3464794
Melanoma Res. 2010 Dec;20(6):485-95
pubmed: 20856146
Br J Dermatol. 2006 Sep;155(3):552-6
pubmed: 16911280
Clin Cancer Res. 2008 Nov 1;14(21):6821-8
pubmed: 18980976
Cancer Cytopathol. 2015 Jul;123(7):394-400
pubmed: 25711993
Acta Cytol. 1985 Nov-Dec;29(6):983-8
pubmed: 3866463
Crit Rev Oncol Hematol. 2011 May;78(2):112-26
pubmed: 20570171
Curr Opin Oncol. 2010 May;22(3):169-77
pubmed: 20168231
J Clin Oncol. 2010 Feb 10;28(5):847-52
pubmed: 20065175
Nat Commun. 2014;5:3116
pubmed: 24445538
J Cutan Pathol. 2019 Dec;46(12):965-972
pubmed: 31233225
Cancer. 2001 Aug 25;93(4):263-8
pubmed: 11507700
Cancer Cytopathol. 2018 Mar;126(3):179-189
pubmed: 29385322
Ann Surg Oncol. 2006 Nov;13(11):1511-6
pubmed: 17009151
Diagn Cytopathol. 2002 Nov;27(5):286-90
pubmed: 12411994
EJC Suppl. 2013 Sep;11(2):81-91
pubmed: 26217116
Eur J Surg Oncol. 2017 Aug;43(8):1509-1516
pubmed: 28262276
Acta Cytol. 2019;63(1):10-16
pubmed: 30396186
Diagn Cytopathol. 1991;7(4):380-6
pubmed: 1935517
Pathol Res Pract. 2020 Jun;216(6):152923
pubmed: 32303388
Am J Clin Pathol. 2007 Mar;127(3):385-97
pubmed: 17276948
Mayo Clin Proc. 2012 Apr;87(4):328-34
pubmed: 22469345
Cancer. 2000 Aug 25;90(4):252-7
pubmed: 10966567
Acta Cytol. 2014;58(5):478-82
pubmed: 25359156
Mod Pathol. 2011 Aug;24(8):1031-5
pubmed: 21478825
Am J Surg Pathol. 2008 Sep;32(9):1291-8
pubmed: 18636017
Cancer. 1999 Feb 25;87(1):37-42
pubmed: 10096358
J Surg Oncol. 1980;15(3):229-34
pubmed: 7431919
Cancer. 2020 Jan 1;126(1):86-97
pubmed: 31584722
Am J Clin Pathol. 2012 Nov;138(5):670-7
pubmed: 23086767
Cytopathology. 1991;2(5):229-37
pubmed: 1782361
Oncologist. 2020 Feb;25(2):e291-e301
pubmed: 32043781
Surg Gynecol Obstet. 1963 Sep;117:341-5
pubmed: 14080349
Crit Rev Oncol Hematol. 2021 Feb;158:103208
pubmed: 33383207
Diagn Cytopathol. 2019 Oct;47(10):1018-1023
pubmed: 31260174
Cancer Cytopathol. 2022 Jan;130(1):18-29
pubmed: 34310059
Cancer. 2000 Jun 25;90(3):162-6
pubmed: 10896329
Histopathology. 2011 Jun;58(7):1001-12
pubmed: 21143519
Acta Derm Venereol. 2015 May;95(5):516-24
pubmed: 25520039
J Am Acad Dermatol. 2019 Jan;80(1):208-250
pubmed: 30392755
Eur J Cancer. 2014 Sep;50(13):2280-8
pubmed: 24999208
Am J Surg Pathol. 2016 Nov;40(11):1484-1495
pubmed: 27565001
Hum Pathol. 2016 Oct;56:134-42
pubmed: 27327192
Ann Surg Oncol. 2006 Dec;13(12):1682-9
pubmed: 17063307
Cancer. 2008 Apr 25;114(2):94-101
pubmed: 18260089
G Ital Dermatol Venereol. 2020 Apr;155(2):126-145
pubmed: 32394673
Patol Pol. 1991;42(3):73-8
pubmed: 1845482
Diagn Cytopathol. 2014 Feb;42(2):143-6
pubmed: 23729392
Cancer Cytopathol. 2012 Feb 25;120(1):52-61
pubmed: 21793228
J Oncol. 2012;2012:647684
pubmed: 22792102
Monogr Clin Cytol. 2018;23:102-112
pubmed: 29131006
MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):591-6
pubmed: 26042651
Br J Dermatol. 2008 Aug;159(2):370-8
pubmed: 18565182
Melanoma Res. 2010 Jun;20(3):203-11
pubmed: 20335819
J Clin Pathol. 2022 Jan;75(1):45-49
pubmed: 33509946
Diagn Cytopathol. 2013 Oct;41(10):847-51
pubmed: 23554410
J Clin Oncol. 2009 Oct 20;27(30):4994-5000
pubmed: 19738131
Mod Pathol. 2015 Apr;28(4):487-97
pubmed: 25341653
J Transl Med. 2010 Jul 14;8:67
pubmed: 20630094
Cytopathology. 1991;2(3):137-47
pubmed: 1932577
J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):403-8
pubmed: 9091471
Cancer Cytopathol. 2014 Oct;122(10):779-85
pubmed: 24954720
Mod Pathol. 2021 Jan;34(Suppl 1):62-77
pubmed: 33110239
J Am Acad Dermatol. 2000 May;42(5 Pt 1):735-40
pubmed: 10775847
Melanoma Res. 2009 Apr;19(2):87-93
pubmed: 19190520
Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):445-50
pubmed: 22495377
Am J Clin Pathol. 2013 Nov;140(5):635-42
pubmed: 24124141